Case reports of patients with monogenic mutations in the IL-23/IL-17 pathway indicate that, physiologically, IL-23 and IL-17 are involved in maintaining mucosa barrier and protecting the body against bacterial and fungal infections. This evidence concerns the gene IL17A and fungal infectious disease.